DETERMINATION OF SUB-MICROGRAM QUANTITIES OF CLONIDINE IN BIOLOGICAL-FLUIDS

被引:24
作者
CHU, LC
BAYNE, WF
TAO, FT
SCHMITT, LG
SHAW, JE
机构
[1] Alza Corporation, Palo Alto, California
关键词
Antihypertensives—clonidine; GLC analysis in plasma and urine; Clonidine—GLC analysis in plasma and urine; GLC—analysis; clonidine in plasma and urine;
D O I
10.1002/jps.2600680122
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A sensitive and specific GLC method using electron‐capture detection was developed for clonidine in plasma and urine. Di‐perfluoroacyl derivatives of both clonidine and the 4‐methyl analog of clonidine (used as an internal standard) were formed, and an extraction process was developed for the removal of excess derivatization reagent and endogenous biological compounds; the assay permitted quantification of 25 pg of clonidine/ml in a 4‐ml plasma sample. The assay was used to elucidate the time course of plasma concentrations in a normotensive subject following oral administration of 50, 100, and 200 μg of clonidine hydrochloride and also to determine unchanged drug excreted in the urine. Copyright © 1979 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:72 / 74
页数:3
相关论文
共 11 条
  • [1] PHYSIOLOGICAL DISPOSITION OF 2-(2,6-DICHLOROANILINO)-2-IMIDAZOLINE (ST-155)
    CHO, AK
    CURRY, SH
    [J]. BIOCHEMICAL PHARMACOLOGY, 1969, 18 (02) : 511 - &
  • [2] DARDA S, 1975, RECENT ADV HYPERTENS, V2, P375
  • [3] DAVIES DS, 1977, CLIN PHARMACOL THER, V21, P593
  • [4] DOLLERY CT, 1976, CLIN PHARMACOL THER, V19, P11
  • [5] DRAFFAN GH, 1975, 3RD P INT S MASS SPE
  • [6] DRAFFAN GH, 1975, 2ND P INT C STABL IS, P149
  • [7] EDLUND PO, 1977, ACTA PHARMACOL TOX, V40, P145
  • [8] LEIBRAND RJ, 1973, RES DEV SEP, P32
  • [9] REHBINDER D, 1974, MODERN ASPECTS TREAT, P3
  • [10] REID JL, 1977, CLIN PHARMACOL THER, V21, P375